HKEX:0512 Short term 20 days. Potential profit 11%HKEX:512
Buy in at 5.21
Cut loss at 4.98
Target at 5.79
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.09 EUR
306.82 M EUR
1.45 B EUR
998.72 M
About GRAND PHARMACEUTICAL GROUP LTD
Sector
Industry
CEO
Chao Zhou
Website
Headquarters
Hong Kong
Founded
1995
FIGI
BBG002JCLZN2
Grand Pharmaceutical Group Ltd. is an investment holding company, which engages in the development, manufacture and distribution of pharmaceutical products. Its products offer ophthalmic medicines for anti-bacterial, antibiotics, antipyretic and analgesic use. It operates through the following geographical segments: The People's Republic of China (PRC), America, Europe, Asia other than the PRC, and Others. The company was founded on October 18, 1995 and is headquartered in Hong Kong.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of MX6A is 0.84 EUR — it has increased by 4.35% in the past 24 hours. Watch GRAND PHARMACEUTICAL GROUP LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange GRAND PHARMACEUTICAL GROUP LIMITED stocks are traded under the ticker MX6A.
MX6A stock has risen by 27.27% compared to the previous week, the month change is a 23.53% rise, over the last year GRAND PHARMACEUTICAL GROUP LIMITED has showed a 44.83% increase.
We've gathered analysts' opinions on GRAND PHARMACEUTICAL GROUP LIMITED future price: according to them, MX6A price has a max estimate of 0.91 EUR and a min estimate of 0.91 EUR. Watch MX6A chart and read a more detailed GRAND PHARMACEUTICAL GROUP LIMITED stock forecast: see what analysts think of GRAND PHARMACEUTICAL GROUP LIMITED and suggest that you do with its stocks.
MX6A reached its all-time high on May 9, 2025 with the price of 0.84 EUR, and its all-time low was 0.38 EUR and was reached on Feb 1, 2024. View more price dynamics on MX6A chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MX6A stock is 4.19% volatile and has beta coefficient of 0.72. Track GRAND PHARMACEUTICAL GROUP LIMITED stock price on the chart and check out the list of the most volatile stocks — is GRAND PHARMACEUTICAL GROUP LIMITED there?
Yes, you can track GRAND PHARMACEUTICAL GROUP LIMITED financials in yearly and quarterly reports right on TradingView.
GRAND PHARMACEUTICAL GROUP LIMITED is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
MX6A net income for the last half-year is 113.17 M EUR, while the previous report showed 186.22 M EUR of net income which accounts for −39.23% change. Track more GRAND PHARMACEUTICAL GROUP LIMITED financial stats to get the full picture.
Yes, MX6A dividends are paid annually. The last dividend per share was 0.03 EUR. As of today, Dividend Yield (TTM)% is 3.48%. Tracking GRAND PHARMACEUTICAL GROUP LIMITED dividends might help you take more informed decisions.
GRAND PHARMACEUTICAL GROUP LIMITED dividend yield was 5.42% in 2024, and payout ratio reached 36.88%. The year before the numbers were 6.36% and 48.51% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 11, 2025, the company has 11.99 K employees. See our rating of the largest employees — is GRAND PHARMACEUTICAL GROUP LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GRAND PHARMACEUTICAL GROUP LIMITED EBITDA is 325.51 M EUR, and current EBITDA margin is 21.87%. See more stats in GRAND PHARMACEUTICAL GROUP LIMITED financial statements.
Like other stocks, MX6A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRAND PHARMACEUTICAL GROUP LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GRAND PHARMACEUTICAL GROUP LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GRAND PHARMACEUTICAL GROUP LIMITED stock shows the strong buy signal. See more of GRAND PHARMACEUTICAL GROUP LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.